Regarding proposals to Vigmed's annual general meeting 2017

The nomination committee of Vigmed Holding AB has notified the company that, in view of Vigmed's new ownership structure, the nomination committee will not submit any proposals to the annual general meeting 2017. 

Vigmed's new majority shareholder, Greiner Bio-One GmbH ("GBO"), has notified Vigmed that GBO will submit proposals to the annual general meeting 2017 as soon as possible. Vigmed will announce the proposals as soon as they have been received by the company.



For further information contact:

Chairman of the Board Sten Dahlborg, +46 708-369 419

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.



Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG). Remium Nordic AB is the Company’s Certified Advisor.Additional information about the company can be found on Vigmed’s website:
  www.vigmed.com/investor  

Tags:

About Us

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and the company has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information can be found on Vigmed’s home page: www.vigmed.com

Subscribe

Documents & Links